Showing results (441-450 of 477) with videos related to

Sort By:
Pageof 48
Scientific Reports|September 15, 2016
Six Versus Twelve Months Clopidogrel Therapy After Drug-Eluting Stenting in Patients With Acute Coronary Syndrome: An ISAR-SAFE Study Subgroup AnalysisRaphaela Lohaus, Jonathan Michel, Katharina Mayer, et al.
Revista Espanola De Cardiologia (English Ed.)|December 28, 2021
Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromesShqipdona Lahu, Michael Behnes, Gjin Ndrepepa, et al.
The New England Journal of Medicine|May 24, 2008
Facilitated PCI in patients with ST-elevation myocardial infarctionStephen G Ellis, Michal Tendera, Mark A de Belder, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|May 24, 2024
Frequency of periprocedural myocardial injury and infarction stratified by cardiac troponin I and cardiac troponin TPruthvi C Revaiah, Tsung-Ying Tsai, Bo Wang, et al.
American Heart Journal|September 2, 2020
Rationale and design of the MULTISTARS AMI Trial: A randomized comparison of immediate versus staged complete revascularization in patients with ST-segment elevation myocardial infarction and multivessel diseaseBarbara E Stähli, Ferdinando Varbella, Bettina Schwarz, et al.
JACC. Cardiovascular Interventions|December 23, 2017
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombosis by an Interdisciplinary Global European Effort RegistryThea C Godschalk, Robert A Byrne, Tom Adriaenssens, et al.
JACC. Cardiovascular Interventions|September 10, 2021
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent ImplantationRoxana Mehran, Davide Cao, Dominick J Angiolillo, et al.
Circulation|October 29, 2020
Ticagrelor or Prasugrel in Patients With ST-Segment-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary InterventionAlp Aytekin, Gjin Ndrepepa, Franz-Josef Neumann, et al.
JACC. Cardiovascular Interventions|June 17, 2019
Updated Expert Consensus Statement on Platelet Function and Genetic Testing for Guiding P2Y<sub>12</sub> Receptor Inhibitor Treatment in Percutaneous Coronary InterventionDirk Sibbing, Daniel Aradi, Dimitrios Alexopoulos, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|December 27, 2019
Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trialMariusz Tomaniak, Ply Chichareon, Kuniaki Takahashi, et al.
Pageof 48